Splenic Infarction with Aortic Thrombosis in COVID-19

Sztajnbok, Jaques; Brasil, Lucas Mendes Cunha de Resende; Romero, Luis Arancibia; Ribeiro, Ana Freitas; Vidal, Jose Ernesto; Figueiredo-Melo, Claudia; Sant'Ana Malaque, Ceila Maria

Coronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic thrombosis, which evolved despite the prophylactic use of low-molecular-weight heparin (LMWH), in a 60-year-old female patient with COVID-19. The patient was treated clinically with a therapeutic dose of LMWH, followed by warfarin, and eventually presented a favorable outcome. We also present a review of the literature regarding SI in patients with COVID-19.